M&A

News

Healthcare hits 2-yr M&A high, bucking trend

According to data released by LSEG Deals Intelligence, the healthcare sector saw a 35% increase on last year’s deals, reaching $174.6 billion in the first half of 2023 – a

News

Shionogi agrees $140m deal to buy antibiotic biotech Qpex

While most pharma companies have exited the antibiotics area, Japanese dru

News

Lilly bets $2.4bn on Dice’s immune disease platform

Eli Lilly has struck a $2.4 billion deal to buy Dice Therapeutics and its drug discovery and development platform for oral, small molecule therapies for immunological dise

News

Novartis builds hefty IgAN pipeline with $3.5bn Chinook buy

Further evidence of big pharma’s return to M&A dealmaking in 2023 has come this morning from Novartis, which has just agreed a takeover of rival Chinook Therapeutics f

News

Novo Nordisk in talks to buy device maker Biocorp

Danish pharma group Novo Nordisk has revealed it is in exclusive negotiations that could result in the acquisition of a controlling stake in Biocorp, a French company that

News

Flurry of deals in biotech as M&A activity picks up

After a slow couple of years, there are signs that biotech M&A activity is coming back into vogue, and a series of small transactions announced in the last few days pr

Healthcare hits 2-yr M&A high, bucking trend

Shionogi agrees $140m deal to buy antibiotic biotech Qpex

Lilly bets $2.4bn on Dice’s immune disease platform

Novartis builds hefty IgAN pipeline with $3.5bn Chinook buy

Novo Nordisk in talks to buy device maker Biocorp

Flurry of deals in biotech as M&A activity picks up

Are Makary's priority review vouchers about to be canned?

Securing your ROI: Turning post-acquisition integration into...

M&A

Editor's Picks